RA
BDSI

Royce & Associates’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Royce & Associates’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,406,069
Closed -$7.46M – 1041
2021
Q4 		$7.46M Buy
2,406,069
+815,418
+51% +$2.74M 0.06% 471
2021
Q3 		$5.74M Sell
1,590,651
-631,856
-28% -$2.38M 0.04% 554
2021
Q2 		$7.96M Buy
2,222,507
+299,698
+16% +$1.06M 0.05% 488
2021
Q1 		$7.52M Buy
+1,922,809
New +$7.94M 0.05% 516
2018
Q4 		– Sell
-483,600
Closed -$1.35M – 1254
2018
Q3 		$1.35M Sell
483,600
-1,717,200
-78% -$4.82M 0.01% 883
2018
Q2 		$6.49M Buy
2,200,800
+352,200
+19% +$835K 0.04% 517
2018
Q1 		$4.16M Hold
1,848,600
– – 0.03% 621
2017
Q4 		$5.45M Buy
1,848,600
+555,800
+43% +$1.54M 0.04% 558
2017
Q3 		$3.81M Buy
+1,292,800
New +$3.94M 0.03% 658
2017
Q1 		– Sell
-551,200
Closed -$965K – 1162
2016
Q4 		$965K Sell
551,200
-991,700
-64% -$2.03M 0.01% 945
2016
Q3 		$4.17M Buy
1,542,900
+160,000
+12% +$406K 0.03% 656
2016
Q2 		$3.26M Sell
1,382,900
-454,900
-25% -$1.26M 0.02% 704
2016
Q1 		$5.94M Buy
1,837,800
+350,000
+24% +$1.29M 0.04% 553
2015
Q4 		$7.13M Buy
1,487,800
+87,200
+6% +$494K 0.04% 518
2015
Q3 		$7.79M Buy
1,400,600
+942,000
+205% +$6.95M 0.04% 529
2015
Q2 		$3.65M Buy
+458,600
New +$3.94M 0.02% 805

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Royce & Associates's BDSI Position: Q1 2022 in Review

Royce & Associates sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 2,406,069 shares — an estimated $7.46M sold.

Royce & Associates first reported a position in BDSI in Q2 2015 and held it in 16 quarters. The position peaked at $7.96M in Q2 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Royce & Associates reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Royce & Associates sold 2,406,069 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $7.46M.
  • Royce & Associates first reported a position in BioDelivery Sciences International, Inc. in Q2 2015 and held it in 16 quarters.
  • Royce & Associates's BioDelivery Sciences International, Inc. position peaked at $7.96M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.